These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia. Baron F; Labopin M; Tischer J; Ciceri F; Raiola AM; Blaise D; Sica S; Vydra J; Fanin R; Diez-Martin JL; Bulabois CE; Stölzel F; Busca A; Jindra P; Koc Y; Chevallier P; Forcade E; Rösler W; Passweg J; Kulagin A; Carella AM; Simand C; Bazarbachi A; Pioltelli P; Nagler A; Mohty M Bone Marrow Transplant; 2022 Nov; 57(11):1657-1663. PubMed ID: 35978005 [TBL] [Abstract][Full Text] [Related]
68. The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party. Rubio MT; Savani BN; Labopin M; Polge E; Niederwieser D; Ganser A; Schwerdtfeger R; Ehninger G; Finke J; Renate A; Craddock C; Kröger N; Hallek M; Jindra P; Mohty M; Nagler A J Hematol Oncol; 2016 Aug; 9(1):65. PubMed ID: 27488518 [TBL] [Abstract][Full Text] [Related]
69. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation. Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744 [TBL] [Abstract][Full Text] [Related]
70. Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia. Pearce KF; Lee SJ; Haagenson M; Petersdorf EW; Norden J; Collin MP; Klein JP; Spellman SR; Lowerson SA; Davies S; Dickinson AM Haematologica; 2012 Jul; 97(7):1014-9. PubMed ID: 22271889 [TBL] [Abstract][Full Text] [Related]
71. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission. Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Morishige S; Maruyama Y; Ikegame K; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Yanada M Transplant Cell Ther; 2021 Apr; 27(4):334.e1-334.e11. PubMed ID: 33836881 [TBL] [Abstract][Full Text] [Related]
72. Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT. Loke J; Labopin M; Craddock C; Niederwieser D; Cornelissen J; Afansayev B; Jindra P; Maertens J; Blaise D; Boriskina K; Gramatzki M; Ganser A; Savani B; Mohty M; Nagler A Bone Marrow Transplant; 2021 Mar; 56(3):614-621. PubMed ID: 33009514 [TBL] [Abstract][Full Text] [Related]
73. Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era. Majhail NS; Chitphakdithai P; Logan B; King R; Devine S; Rossmann SN; Hale G; Hartzman RJ; Karanes C; Laport GG; Nemecek E; Snyder EL; Switzer GE; Miller J; Navarro W; Confer DL; Levine JE Biol Blood Marrow Transplant; 2015 Jan; 21(1):142-50. PubMed ID: 25445638 [TBL] [Abstract][Full Text] [Related]
74. [Efficacy of donor lymphocyte infusion in patients after different types of allogeneic hematopoietic stem cell transplantation]. Slesarchuk OA; Babenko EV; Semenova EV; Bondarenko SN; Éstrina MA; Morozova EV; Paina OV; Vavilov VN; Smirnov BI; Zubarovskaia LS; Afanas'ev BV Ter Arkh; 2013; 85(7):26-33. PubMed ID: 24137944 [TBL] [Abstract][Full Text] [Related]
75. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017! Kindwall-Keller TL; Ballen KK Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462 [TBL] [Abstract][Full Text] [Related]
76. Use of alternative donors for allogeneic stem cell transplantation. Anasetti C Hematology Am Soc Hematol Educ Program; 2015; 2015():220-4. PubMed ID: 26637725 [TBL] [Abstract][Full Text] [Related]
77. Mismatched unrelated alternative donors for hematological malignancies. Sebastian Schäfer H; Finke J Semin Hematol; 2016 Apr; 53(2):77-81. PubMed ID: 27000730 [TBL] [Abstract][Full Text] [Related]
78. New strategies for mismatched unrelated donor (MMUD) hematopoietic cell transplant (HCT). Arslan S; Al Malki MM Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):74-82. PubMed ID: 36485163 [TBL] [Abstract][Full Text] [Related]
79. Single Antigen-Mismatched Unrelated Hematopoietic Stem Cell Transplantation Using High-Dose Post-Transplantation Cyclophosphamide Is a Suitable Alternative for Patients Lacking HLA-Matched Donors. Jorge AS; Suárez-Lledó M; Pereira A; Gutierrez G; Fernández-Avilés F; Rosiñol L; Llobet N; Solano T; Urbano-Ispízua Á; Rovira M; Martínez C Biol Blood Marrow Transplant; 2018 Jun; 24(6):1196-1202. PubMed ID: 29410343 [TBL] [Abstract][Full Text] [Related]